Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A1 | P04798 | 6/20 | 0.98 |
| ▸ | CYP1A2 | P05177 | 6/20 | 0.98 |
| ▸ | CYP1B1 | Q16678 | 6/20 | 0.98 |
| ▸ | POLB | P06746 | 2/20 | 0.98 |
| ▸ | CYP19A1 | P11511 | 7/20 | 0.81 |
| ▸ | CYP3A4 | P08684 | 5/20 | 0.81 |
| ▸ | TP53 | P04637 | 3/20 | 0.81 |
| ▸ | CA12 | O43570 | 3/20 | 0.81 |
| ▸ | CA4 | P22748 | 3/20 | 0.81 |
| ▸ | CYP2C19 | P33261 | 3/20 | 0.81 |
| ▸ | CA7 | P43166 | 3/20 | 0.81 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.81 |
| ▸ | MAPT | P10636 | 3/20 | 0.81 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.81 |
| ▸ | XDH | P47989 | 2/20 | 0.81 |
| ▸ | HPGD | P15428 | 2/20 | 0.81 |
| ▸ | PKM | P14618 | 2/20 | 0.81 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.81 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.81 |
| ▸ | DPP4 | P27487 | 2/20 | 0.81 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Homoeriodictyol SCHEMBL1505910 | 1.00 | CYP1A1 (0.98) | CYP1A1CYP1A2CYP1B1POLBCYP19A1 | |
| Homoeriodictyol SCHEMBL30383489 | 0.99 | CYP1A1 (1.00) | CYP1A1CYP1A2CYP1B1POLBCYP19A1 | |
| Homoeriodictyol SCHEMBL39497 | 0.99 | CYP1A1 (1.00) | CYP1A1CYP1A2CYP1B1POLBCYP19A1 | |
| Homoeriodictyol SCHEMBL2307702 | 0.99 | CYP1A1 (1.00) | CYP1A1CYP1A2CYP1B1POLBCYP19A1 | |
| Homoeriodictyol SCHEMBL29411740 | 0.99 | CYP1A1 (1.00) | CYP1A1CYP1A2CYP1B1POLBCYP19A1 | |
| Homoeriodictyol SCHEMBL30016824 | 0.99 | CYP1A1 (1.00) | CYP1A1CYP1A2CYP1B1POLBCYP19A1 | |
| Homoeriodictyol SCHEMBL2024548 | 0.98 | CYP1A1 (0.98) | CYP1A1CYP1A2CYP1B1POLBCYP19A1 | |
| Homoeriodictyol SCHEMBL2019518 | 0.98 | CYP1A1 (0.98) | CYP1A1CYP1A2CYP1B1POLBCYP19A1 | |
| Homoeriodictyol SCHEMBL3422048 | 0.97 | CYP1A1 (0.95) | CYP1A1CYP1A2CYP1B1POLBCYP19A1 | |
| SCHEMBL29501694 | 0.92 | CYP1A1 (0.87) | CYP1A1CYP1A2CYP1B1POLBCYP19A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12004542-B2 | Use and methods of 1,3-propanediol to improve taste and/or off-taste qualities | PRIMIENT COVATION LLC (US) | 2024-06-11 | — | — | US | disclosed |
| CN-114867362-A | Use and method of 1, 3-propanediol for improving taste and/or off-taste quality | 杜邦塔特和莱尔生物产品有限责任公司 | 2022-08-05 | — | — | CN | disclosed |
| WO-2021087194-A1 | USE AND METHODS OF 1,3-PROPANEDIOL TO IMPROVE TASTE AND/OR OFF-TASTE QUALITIES | DuPont Tate & Lyle Bio Products Co., LLC (US) | 2021-05-06 | — | — | WO | disclosed |
| US-20210127724-A1 | USE AND METHODS OF 1,3-PROPANEDIOL TO IMPROVE TASTE AND/OR OFF-TASTE QUALITIES | DuPont Tate & Lyle Bio Products Co., LLC (US) | 2021-05-06 | — | — | US | disclosed |
| US-20020188019-A1 | Use of hydroxyflavanones for masking bitter taste | SYMRISE AG (DE) | 2002-12-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020188019-A1 | Use of hydroxyflavanones for masking bitter taste | TAS2R60, TAS2R50, TAS2R30 | CYP1A1 1504/4885CYP1A2 630/4885CYP1B1 1772/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.